Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Clinical Pathology

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1309/5XW3L8LU445QWGQRPMID 16468415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MDM2 is a central node in the p53 pathway: 12 years and counting.

  2005cited by this paper
• Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c‐erbB‐2 with biological markers of proliferation and overall survival in breast cancer

  2005cited by this paper
• Abnormal expression of MDM-2 in breast carcinomas

  2005cited by this paper
• Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers

  2004cited by this paper
• Expression of c-erbB-2 and p53 in Breast Carcinoma Patients: Comparison with Traditional Prognostic Factors and Survival

  2004cited by this paper
• Regulating the p53 system through ubiquitination

  2004cited by this paper
• Prognostic implication of p53 protein expression in relation to nuclear pleomorphism and the MIB-1 counts in breast cancer

  2004cited by this paper
• Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.

  2004cited by this paper
• ATM and related protein kinases: safeguarding genome integrity

  2003cited by this paper
• TP53 and breast cancer

  2003cited by this paper
• Mammalian target of rapamycin: a new molecular target for breast cancer.

  2003cited by this paper
• PTEN: One Gene, Many Syndromes

  2003cited by this paper
• Maspin expression in invasive breast cancer: association with other prognostic factors

  2003cited by this paper
• Coordinated regulation of life and death by RB

  2003cited by this paper
• Expression of maspin is up‐regulated during the progression of mammary ductal carcinoma

  2003cited by this paper
• Germline TP53 mutations and Li‐Fraumeni syndrome

  2003cited by this paper
• TP53, hChk2, and the Li-Fraumeni syndrome.

  2003cited by this paper
• Mutation analysis of the CHK2 gene in breast carcinoma and other cancers

  2002cited by this paper
• An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma.

  2002cited by this paper
• p53, mitosis, apoptosis and necrosis as prognostic indicators of long-term survival in breast cancer.

  2002cited by this paper
• CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

  2002cited by this paper
• p53 and c-erbB-2 but not bcl-2 are predictive of metastasis-free survival in breast cancer patients receiving post-mastectomy adjuvant radiotherapy in Taiwan.

  2002cited by this paper
• The p53 pathway in breast cancer

  2002cited by this paper
• Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

  2002cited by this paper
• Expression of maspin predicts poor prognosis in breast‐cancer patients

  2002cited by this paper
• The retinoblastoma tumour suppressor in development and cancer

  2002cited by this paper
• Lack of prognostic significance of nm23 expression in human primary breast cancer.

  2002cited by this paper
• The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma.

  2002cited by this paper
• LKB1 — A master tumour suppressor of the small intestine and beyond

  2002cited by this paper
• Nm23 Gene Product Expression in Invasive Breast Cancer

  2002cited by this paper
• Decreased nm23 expression, but not Ki-67 labeling index, is significantly correlated with lymph node metastasis of breast invasive ductal carcinoma.

  2002cited by this paper
• Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.

  2001cited by this paper
• Contributions in the domain of cancer research: Review¶Negative regulators of cyclin-dependent kinases and their roles in cancers

  2001cited by this paper
• Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort.

  2001cited by this paper
• Assessing TP53 status in human tumours to evaluate clinical outcome

  2001cited by this paper
• Prognostic Value of Cytosolic p53 Protein in Breast Cancer

  2001cited by this paper
• Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers

  2001cited by this paper
• p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast.

  2001cited by this paper
• Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast

  2001cited by this paper
• CGH, cDNA and Tissue Microarray Analyses Implicate FGFR2 Amplification in a Small Subset of Breast Tumors

  2001cited by this paper
• TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

  2001cited by this paper
• Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.

  2001cited by this paper
• Wnt signaling in breast cancer: have we come full circle?

  2001cited by this paper
• Disruption of the ATM gene in breast cancer.

  2001cited by this paper
• PTEN deficiency: a role in mammary carcinogenesis

  2001cited by this paper
• Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer.

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Prognostic value of p53 protein expression in breast cancer; An immunohistochemical analysis of frozen sections in 514 Japanese women

  2001cited by this paper
• [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].

  2001cited by this paper
• The INK4a/ARF network in tumour suppression

  2001cited by this paper
• Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

  2001cited by this paper
• Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.

  2000cited by this paper
• Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.

  2000cited by this paper
• Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.

  2000cited by this paper
• P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up.

  2000cited by this paper
• An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers

  2000cited by this paper
• TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.

  2000cited by this paper
• The prognostic value of p53 and c‐erb b‐2 immunostaining is overrated for patients with lymph node negative breast carcinoma

  2000cited by this paper
• β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression

  2000cited by this paper
• Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.

  2000cited by this paper
• Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer.

  2000cited by this paper
• Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclin.

  2000cited by this paper
• Somatic mutations of the APC gene in primary breast cancers.

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.

  2000cited by this paper
• Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.

  1999cited by this paper
• Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

  1999cited by this paper
• Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions

  1999cited by this paper
• Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma

  1999cited by this paper
• Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study

  1999cited by this paper
• Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

  1999cited by this paper
• European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables

  1999cited by this paper
• Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

  1999cited by this paper
• Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.

  1999cited by this paper
• The molecular basis and clinical aspects of Peutz-Jeghers syndrome

  1999cited by this paper
• A serine/threonine kinase gene defective in Peutz–Jeghers syndrome

  1998cited by this paper
• Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer.

  1998cited by this paper
• No significant predictive value of c‐ erbB‐2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

  1998cited by this paper
• Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer.

  1998cited by this paper
• Activation of the ATM kinase by ionizing radiation and phosphorylation of p53.

  1998cited by this paper
• ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins

  1998cited by this paper
• Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers.

  1998cited by this paper
• Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

  1998cited by this paper
• p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer.

  1998cited by this paper
• Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.

  1998cited by this paper
• ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.

  1998cited by this paper
• p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

  1998cited by this paper
• NM23-NDP kinase.

  1998cited by this paper
• Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile.

  1998cited by this paper
• p21/waf1/cip1 and mdm‐2 expression in breast carcinoma patients as related to prognosis

  1997cited by this paper
• Expression of drug resistance proteins in breast cancer, in relation to chemotherapy

  1997cited by this paper
• Deletion mapping and linkage analysis provide strong indication for the involvement of the human chromosome region 8p12-p22 in breast carcinogenesis.

  1997cited by this paper
• Detection of p53 gene mutation by rapid PCR‐SSCP and its association with poor survival in breast cancer

  1997cited by this paper
• Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.

  1996cited by this paper
• p53 protein expression in human breast carcinoma: lack of prognostic potential for recurrence of the disease.

  1996cited by this paper
• Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors

  1995cited by this paper
• Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols.

  1995cited by this paper
• Oncogene Protein Co‐Expression Value of Ha-ras, c-myc, c-fos, and p53 as Prognostic Discriminants for Breast Carcinoma

  1995cited by this paper
• Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival.

  1995cited by this paper
• Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.

  1995cited by this paper

• Combined Phytochemical Sulforaphane and Dietary Fiber Inulin Contribute to the Prevention of ER-Negative Breast Cancer via PI3K/AKT/MTOR Pathway and Modulating Gut Microbial Composition

  2025cites this paper
• Patterns of Chromosomal Instability and Clonal Heterogeneity in Luminal B Breast Cancer: A Pilot Study

  2024cites this paper
• Current status and future prospective of breast cancer immunotherapy.

  2024cites this paper
• Recent advancements in small interfering RNA (siRNA) based therapeutic approach on breast cancer.

  2024cites this paper
• A meta‑ and bioinformatics analysis of maspin expression levels influencing the prognosis of patients with breast cancer

  2024cites this paper
• Utility of bone marrow examination in retinoblastoma and their correlation with hematological features

  2023cites this paper
• Circ_0001955 plays a carcinogenic role in breast cancer via positively regulating GLUT1 via decoying miR‐1299

  2022cites this paper
• MKRN2 inhibits the proliferation of gastric cancer by downregulating PKM2

  2022cites this paper
• Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View

  2022cites this paper
• Compounds from diverse natural origin against triple‐negative breast cancer: A comprehensive review

  2022cites this paper
• Cytogenomic characteristics of murine breast cancer cell line JC

  2021cites this paper
• Large Scale Identification of Osteosarcoma Pathogenic Genes by Multiple Extreme Learning Machine

  2021cites this paper
• P53 Expression in benign Breast Disease Development: A Systematic Review.

  2020cites this paper
• The Polemic Diagnostic Role of TP53 Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers

  2020cites this paper
• Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer.

  2020cites this paper
• Molecular Cytogenomic Characterization of the Murine Breast Cancer Cell Lines C-127I, EMT6/P and TA3 Hauschka

  2020cites this paper
• Gene Therapy as an Emerging Therapeutic Approach to Breast Cancer: New Developments and Challenges

  2020cites this paper
• P53 Expression in benign Breast Disease Development: A Systematic Review

  2020cites this paper
• E6AP goes viral: the role of E6AP in viral- and non-viral-related cancers.

  2019cites this paper
• Overview of the genetic basis toward early detection of breast cancer

  2019cites this paper
• Identification of CDKN2A variants in breast cancer patients in Pakistan.

  2019cites this paper
• A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials

  2019cites this paper
• Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.

  2019cites this paper
• Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors

  2018cites this paper
• P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling

  2018cites this paper
• Chemical genetic approach to identify substrates of CK2 kinase using Mass spectrometry

  2018cites this paper
• Phyllodes tumors of the breast in 2 sisters

  2017cites this paper
• BMP4 in Breast Cancer Growth and Metastasis with Insights into Transcriptional Regulation

  2017cites this paper
• Synthesis, characterization, and cytotoxicity of the plasmid EGFP-p53 loaded on pullulan–spermine magnetic nanoparticles

  2016cites this paper
• Somatic Mutation Theory - Why it's Wrong for Most Cancers

  2016cites this paper
• Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer

  2016cites this paper
• Characterization of the catalytic CK2 subunits with substitutions at residues involved in inhibitor binding

  2016cites this paper
• Breast Cancer Progression and Current Therapeutic Approach

  2015cites this paper
• Revista de Medicina e Saúde de Brasília ARTIGO DE REVISÃO

  2015cites this paper
• BLID: A Novel Tumor-Suppressor Gene

  2015cites this paper
• Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin.

  2015cites this paper
• Long non-coding RNA growth arrest-specific transcript 5 in tumor biology.

  2015cites this paper
• Classification of Meningioma Using Immunogenic Antigens

  2014cites this paper
• Deleted in Liver Cancer-1 (DLC1): An Emerging Metastasis Suppressor Gene

  2014cites this paper
• Cell-Cell Communication in the Tumor Microenvironment, Carcinogenesis, and Anticancer Treatment

  2014cites this paper
• Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.

  2014cites this paper
• Identification and Comparison of Aberrant Key Regulatory Networks in Breast, Colon, Liver, Lung, and Stomach Cancers through Methylome Database Analysis

  2014cites this paper
• BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration

  2014cites this paper
• PRDI-BF1-RIZ domain of retinoblastoma protein-interacting zinc finger gene 1 induces apoptosis and exerts anticancer activity in esophageal squamous cell carcinoma cells

  2014cites this paper
• P16 and P53 Play Distinct Roles in Different Subtypes of Breast Cancer

  2013cites this paper
• Active transport of RB protein from the nucleus to the cytoplasm as one of the development mechanisms of HER2-positive breast cancer.

  2013cites this paper
• Association of prediagnostic physical activity with survival following breast cancer diagnosis: influence of TP53 mutation status

  2013cites this paper
• Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories

  2013cites this paper
• Estrogen Alters the Splicing of Type 1 Corticotropin-Releasing Hormone Receptor in Breast Cancer Cells

  2013cites this paper
• ANALISIS DE MUTACIONES EN EL GEN BRCA1 EN MUJERES CON CANCER DE MAMA HEREDOFAMILIAR ATENDIDAS EN LOS SERVICIOS DE ONCOLOGIA DE BUCARAMANGA

  2013cites this paper
• Expression changes of the ETS family of transcription factors associated with chromosomal rearrangements in breast cancer.

  2013cites this paper
• The Nucleolar Aspect of Breast Cancer

  2013cites this paper
• Technological advances in molecular pathology : a journey into the archives

  2013cites this paper
• PTEN regulation of ERK1/2 signaling in cancer

  2012cites this paper
• Expression and Function of the Protein Tyrosine Phosphatase Receptor J (PTPRJ) in Normal Mammary Epithelial Cells and Breast Tumors

  2012cites this paper
• The mechanism involved in the loss of PTEN expression in NSCLC tumor cells.

  2012cites this paper
• Race and the Prognostic Influence of p53 in Women with Breast Cancer

  2012cites this paper
• NEURAL NETWORKS CUM CLOUD COMPUTING APPROACH IN DIAGNOSIS OF CANCER Prof .

  2012cites this paper
• Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance

  2012cites this paper
• Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression.

  2012cites this paper
• The effect of a novel frizzled 8-related antiproliferative factor on in vitro carcinoma and melanoma cell proliferation and invasion

  2012cites this paper
• Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation

  2012cites this paper
• The TP53 16-bp Duplication Polymorphism Is Enriched in Endometriosis Patients

  2012cites this paper
• Anticancer role of MUC1 aptamer–miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation

  2012cites this paper
• The Role of Hsp70 in Cancer: A Study of the Hsp70 / Akt Relationship

  2012cites this paper
• Epithelial Integrity as a Tumor Suppressor Mechanism - The Interplay Between Lkb1 and c-Myc in Breast Cancer Development

  2012cites this paper
• Avaliação do perfil de metilação e expressão do gene CDH1 em Cebus apella como modelo experimental para câncer gástrico

  2012cites this paper
• Neural Network Towards Diagnosis Of Brain Tumor

  2012cites this paper
• Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics

  2012cites this paper
• Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.

  2011cites this paper
• Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?

  2011cites this paper
• THE EXPRESSION OF MISMATCH REPAIR GENES (MLH1 AND MSH2) AND TUMOR SUPPRESSOR GENE (BRCA1 AND P53) IN HUMAN MELANOMA CELL LINES AFTER UVB-IRRADIATION

  2011cites this paper
• Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma.

  2011cites this paper
• International Journal of Biological Sciences

  2011cites this paper
• Breast Cancer: PTEN Expression in Palestinian Women Triple Negative Subtype

  2011cites this paper
• NEURAL NETWORKS TOWARDS MEDICAL DIAGNOSIS

  2011cites this paper
• ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells.

  2011cites this paper
• Molecular markers in breast carcinoma. A study with focus on molecular phenotypes, angiogenesis and stem cells in an African population

  2010influential citation
• Induction of miR-21 by Retinoic Acid in Estrogen Receptor-positive Breast Carcinoma Cells

  2010cites this paper
• Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion?

  2010cites this paper
• Assoziation methylierter Gene im Blut von Mammakarzinompatientinnen mit dem Auftreten zirkulierender Tumorzellen und dem

  2010cites this paper
• Expression of FANCD2 in sporadic breast cancer and clinicopathological analysis

  2010cites this paper
• RB-pathway disruption in breast cancer

  2010cites this paper
• p53 as a Marker of Prognosis in African-American Women with Breast Cancer

  2010influential citation
• Dietary Phenethyl Isothiocyanate Alters Gene Expression in Human Breast Cancer Cells

  2010cites this paper
• Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients.

  2010influential citation
• Tumor dormancy and metastasis.

  2009cites this paper
• Dual usages of single Wilms' tumor 1 immunohistochemistry in evaluation of breast tumors: A preliminary study of 30 cases

  2009cites this paper
• Mammary tumor development from T47-D human breast cancer cells in obese ovariectomized mice with and without estradiol supplements

  2009cites this paper
• Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy

  2009cites this paper
• Rational design of new protein kinases inhibitors of pharmaceutical interest

  2008cites this paper
• Bad seeds produce bad crops: A single stage-process of breast carcinogenesis☆☆☆

  2008cites this paper
• Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.

  2008cites this paper
• Antiviral and Anticancer Activity of Cisplatin Derivatives of Tilorone

  2008cites this paper
• Tailoring to RB: tumour suppressor status and therapeutic response

  2008cites this paper
• Gene transcription increases DNA damage-induced mutagenesis in mammalian stem cells.

  2008cites this paper
• Wnt Signaling Pathway in Invasive Ductal Carcinoma of the Breast: Relationship between β-Catenin, Disheveled and Cyclin D1 Expression

  2008cites this paper
• Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones?

  2008cites this paper
• Do Single Nucleotide Polymorphisms in Xenobiotic Metabolizing Genes Determine Breast Cancer Susceptibility and Treatment Outcomes?

  2008cites this paper
• Natriuretic peptide receptor a as a novel anticancer target.

  2008cites this paper